oasis trial semaglutide Oral 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 🥼🧪Slide Deck: Efficacy and safety

That timeline frustrated a subset of participants in the STEP-1 trial, where earlier intervention correlated with better adherence over the 68-week study period

Although there were differences in magnitude of DMSO effect between tissue types, the affected biological processes by DMSO do not appear to be tissue-specific

Fit, feel, and injury prevention matter more than pace or PRs

While clinical studies have explored its use in topical skincare and wound care, the 100mg formulation provides a high-concentration, cost-effective foundation for longitudinal studies, dose-response curves, and combination protocols particularly when paired with BPC-157 or TB-500